11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues (Q50685144)

17 March 2018

title

11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues (English)

1 reference

17 March 2018

author

Denis R. Joanisse

6

1 reference

17 March 2018

Gunilla Olivecrona

7

object named as

Gunilla Olivecrona

1 reference

17 March 2018

4

Katherine Cianflone

1 reference

17 March 2018

3

William T Festuccia

1 reference

17 March 2018

author name string

Magalie Berthiaume

1

1 reference

17 March 2018

Mathieu Laplante

2

1 reference

17 March 2018

Lorraine P Turcotte

5

1 reference

17 March 2018

Rolf Thieringer

8

1 reference

17 March 2018

Yves Deshaies

9

1 reference

17 March 2018

publication date

31 July 2007

1 reference

17 March 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

17 March 2018

volume

293

1 reference

17 March 2018

issue

4

1 reference

17 March 2018

page(s)

E1045-52

1 reference

17 March 2018

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Effects of insulin, glucocorticoids and adrenaline on the activity of rat adipose-tissue lipoprotein lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

11beta-hydroxysteroid dehydrogenase type 2 in mouse aorta: localization and influence on response to glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Skeletal muscle utilization of free fatty acids in women with visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

AMPK alterations in cardiac physiology and pathology: enemy or ally?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

The effects of cortisol, corticotropin and thyroxine on the synthesis of glycerolipids and on the phosphatidate phosphohydrolase activity in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Fatty acid transport across membranes: relevance to nutrition and metabolic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Hormonal regulation of hepatic soluble phosphatidate phosphohydrolase. Induction by cortisol in vivo and in isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Clearance of artificial triacylglycerol particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Hypercortisolism and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Glucocorticoids inhibit the transcriptional response of the uncoupling protein-1 gene to adrenergic stimulation in a brown adipose cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Fasting increases plasma membrane fatty acid-binding protein (FABP(PM)) in red skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Muscle palmitate uptake and binding are saturable and inhibited by antibodies to FABP(PM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00276.2007

10.1152/AJPENDO.00276.2007

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018